Skip to main content
Premium Trial:

Request an Annual Quote

Three Massachusetts Hospitals Using Protein Forest's Proteomics Software

NEW YORK (GenomeWeb News) – Three Massachusetts research hospitals will evaluate Protein Forest’s bioinformatics software in separate disease studies, the company said Friday.
 
The Whitehead Institute, the Proteomics and Mass Spectrometry Facility at the University of Massachusetts Medical School, and Harvard Medical School will use the company’s Mass Spec Results Analysis Tool (MSRAT) to study data generated using the company’s digital ProteomeChip system.
 
The studies will involve seeking biomarkers for glial tumors, identifying prostate cancer markers in urine, and studying diseases linked to MHC class I and class II peptides from T cells, the Lexington, Mass.-based company said. 
 
The MSRAT software is used to help correlate protein expression, post-translational modifications and pl isoformes with diseases from mass spectrometry-based proteomics studies, and it uses visualization tools such as histograms, Venn diagrams, differential heat maps, and virtual 2D gel maps to assist in interpreting MS data.
 
Financial terms of the agreements were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.